Real-world efficacy of oral azvudine in hospitalized patients with COVID-19: A multicenter retrospective cohort study
During the omicron epidemic in China, oral administration of azvudine was associated with a reduced risk of the composite outcome and all-cause mortality in COVID-19 patients.
Authors
- Min Tang (ORCID: https://orcid.org/0000-0003-2751-2068)
- Youhong Guan (ORCID: https://orcid.org/0000-0002-0761-2005)
- Daxiong Zeng
- Guanghe Fei (ORCID: https://orcid.org/0000-0003-0064-2073)
- Ran Wang (ORCID: https://orcid.org/0000-0002-8199-6895)
- Pulin Li
- Rui Han (ORCID: https://orcid.org/0000-0003-2281-7129)
Institutions
- Anhui Medical University (CN)
- Soochow University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- First Affiliated Hospital of Soochow University (CN)
- Third People's Hospital of Hefei (CN)
- Hefei Infectious Disease Hospital (CN)
Publication Details
- Journal
- Journal of Infection and Public Health
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1016/j.jiph.2025.102987
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00